Lazard Asset Management (the manager of Zurich’s Global Thematic Share Fund) recently evolved its investment thinking, introducing new themes into Global Thematic that more precisely capture the long term wealth creation opportunities identified by the investment team.
One of the new themes is ‘First World Health’, which addresses the rising cost of healthcare globally, and specifically in the United States. Healthcare expenditure in the US is approaching 16% of GDP, nearly double the OECD average and it is at risk of becoming unaffordable Innovative companies that are applying technology to improve productivity, or which can offer more cost-effective access to healthcare are interesting candidates for this theme..
In this short video, Lazard’s Portfolio Manager Steve Wreford explains the theme in more detail and gives an example of a stock that is part of the solution, and which he thinks provides wealth-enhancement opportunity.
Zurich Investments’ partnership with Lazard Asset Management extends back nearly 15 years. We are proud to have them as our exclusive investment partner for the Zurich Investments Global Thematic Share Fund. Find out more about Zurich’s Global Thematic Share Fund here, or contact your Zurich representative to discuss how we can help you.
Important information: The content of this publication are the opinions of the writer and is intended as general information only which does not take into account the personal investment objectives, financial situation or needs of any person. It is dated November 2016, is given in good faith and is derived from sources believed to be accurate as at this date, which may be subject to change. It should not be considered to be a comprehensive statement on any matter and should not be relied on as such. Neither Zurich Australia Limited ABN 92 000 010 195 AFSL 232510, nor Zurich Investment Management Limited ABN 56 063 278 400 AFSL 232511 of 5 Blue Street North Sydney NSW 2060, nor any of its related entities, employees or directors (Zurich) give any warranty of reliability or accuracy nor accept any responsibility arising in any way including by reason of negligence for errors and omissions. Zurich recommends investors seek advice from appropriately qualified financial advisers. Zurich and its related entities receive remuneration such as fees, charges and premiums for the financial products which they issue. Details of these payments can be found in the relevant fund Product Disclosure Statement. No part of this document may be reproduced without prior written permission from Zurich.
Past performance is not reliable indicator of future performance. GINN FVHHKJ.00012.ME.036. DFOY-012132-2017